Cognitive behaviour therapy for non-cardiac pain in the chest (COPIC): a multicentre randomized controlled trial with economic evaluation. by Tyrer, Peter et al.
Tyrer, P; Tyrer, H; Cooper, S; Barrett, B; Kings, S; Lazarevic, V;
Bransby-Adams, K; Whittamore, K; Walker, G; McNulty, A; Don-
aldson, E; Midgley, L; McCoy, S; Evered, R; Yang, M; Guo, B;
Lisseman-Stones, Y; Doukani, A; Mulder, R; Morriss, R; Crawford,
M (2015) Cognitive behaviour therapy for non-cardiac pain in the
chest (COPIC): a multicentre randomized controlled trial with eco-
nomic evaluation. BMC Psychol, 3. p. 41. ISSN 2050-7283 DOI:
10.1186/s40359-015-0099-7
Downloaded from: http://researchonline.lshtm.ac.uk/2373866/
DOI: 10.1186/s40359-015-0099-7
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
STUDY PROTOCOL Open Access
Cognitive behaviour therapy for
non-cardiac pain in the chest (COPIC):
a multicentre randomized controlled trial
with economic evaluation
Peter Tyrer1,12*, Helen Tyrer1, Sylvia Cooper1, Barbara Barrett2, Stephanie Kings3, Valentina Lazarevic3,
Kate Bransby-Adams3, Katherine Whittamore3, Gemma Walker3, Antoinette McNulty4, Emma Donaldson5,
Luke Midgley5, Shani McCoy5, Rachel Evered6, Min Yang7, Boliang Guo8, Yvonne Lisseman-Stones9,
Asmae Doukani10, Roger Mulder11, Richard Morriss8 and Mike Crawford1
Abstract
Background: Most patients with chest pain have nothing wrong with their cardiac function. Psychological forms of
treatment for this condition are more likely to be successful than others.
Methods/design: A two-arm parallel controlled randomized trial of standard care versus a modified form of cognitive
behaviour therapy for chest pain (CBT-CP) in patients who have attended emergency hospital services. Inclusion criteria
include (i) emergency attendance more than once in the previous year with chest pain when no physical pathology
has been found, (ii) aged between 16 and 75, (iii) signed consent to take part in the study. Exclusion criteria are (i) under
current psychiatric care, (ii) those who have had new psychotropic drugs prescribed within the last two months, (iii) are
receiving or about to receive a formal psychological treatment. Those satisfying these criteria will be randomized to 4–10
sessions of CBT-CP or to continue with standard care.
Participants are randomized using a remote web-based system using permuted stacked blocks stratified by study centre.
Assessment is carried out at baseline by researchers subsequently masked to allocation and at 6 months and 1 year after
randomization. The primary outcome is the Health Anxiety Inventory score at 6 months, and secondary outcomes are
generalised anxiety and depressive symptoms, the Lucock Health Anxiety Questionnaire adapted for chest pain, visual
analogue scales for chest pain and discomfort (Inskip Scale), the Schedule for Evaluating Persistent Symptoms (SEPS),
health related quality of life, social functioning and medical resource usage. Intention to treat analyses will be carried
out with clinical and functioning data, and a cost-utility analysis will compare differences in total costs and differences
in quality of life using QALYs derived from the EQ-5D. The data will also be linked to another parallel study in New
Zealand where 126 patients with the same inclusion criteria have been treated in a similar trial; the form of analysis of
the combined data has yet to be determined.
Discussion: The morbidity and costs of non-cardiac chest pain are substantial and if a simple psychological treatment
given by health professionals working in medical departments is beneficial it should prove to be of great value.
Combining data with a similar study in New Zealand is an additional asset.
(Continued on next page)
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Background
Chest pain is one of the most common reasons for attend-
ing an Accident & Emergency Department. This is under-
standable as cardiac conditions often present with chest
pain and many sufferers require emergency interventions
to save life. However, only a minority of patients presenting
with chest pain have a demonstrated physical cause for
their conditions. The experience of chest pain, even if not
related to cardiac pathology, is often alarming and frighten-
ing, and if inadequately managed, tends to reinforce rather
than resolve the problems.
Atypical, better termed non-cardiac, chest pain, can have
a number of underlying pathologies. Most importantly, it
can be an indicator of genuine myocardial disease. A re-
cent study of the outcome of 8762 patients attending rapid
access chest pain clinics showed that of 599 patients who
reached the primary end-point (ie died from coronary
heart disease or had a myocardial infarction or had a hos-
pital admission with unstable angina) after a mean of
2.6 years, 194 (32 %) had non-cardiac chest pain. However,
this represented only 2.7 % of the population (6396 people)
with non-cardiac chest pain whereas 16.5 % of those with
angina reached the primary end-point [1]. Those with
identifiable disease therefore only accounted for a minority
of these. There is also an additional group of patients who
already have had clear cardiac disease that has apparently
been treated successfully but who continue to have persist-
ent chest pain that cannot be explained cardiologically. To-
gether, these constitute a psychosomatic majority, who
often suffer greatly from their symptoms and attend
repeatedly with their symptoms, only to be reassured that
they have no active cardiac disease. Approximately 75 % of
these patients satisfy the diagnosis for a mental state dis-
order, mainly panic disorder, depressive and other anxiety
disorders [2]. These problems are not usually recognised as
requiring mental health interventions by either the patients
or their doctors, and, because these problems tend to be
persistent, they tend to become repeat attenders at rapid
access chest pain or cardiology clinics, often get admitted
to hospital for further checks and tests, and yet very few
develop significant cardiac pathology [3].
Cognitive behaviour therapy and related psychological
treatments are normally effective in the treatment of anx-
iety and depressive disorders but have not shown quite
such success in the treatment of non-cardiac chest pain.
Kisely et al [4, 5] have carried out Cochrane systematic
reviews and found 8 randomised trials, increasing to 10 in
their updated review, but the benefits were relatively
modest. They concluded that these trials ‘suggested a
modest to moderate benefit for psychological interven-
tions, particularly those using a cognitive-behavioural
framework, which was largely restricted to the first three
months after the intervention. The evidence for brief in-
terventions was less clear. Further RCTs of psychological
interventions with follow-up periods of at least 12 months
are said to be needed [4]. In their later review they added
that hypnotherapy might be useful [5].
Examination of the reasons for the relatively poor per-
formance of psychological treatments for this condition
suggest three factors handicap progress; (i) the resistance
of patients to the notion of a psychological explanation
for their condition, (ii) the confidence of the therapists
in dealing with a condition that mimics major cardiac
pathology, and (iii) the ability of therapists to deliver
treatment well to such patients. Most well-trained CBT
therapists are psychologists but they do not have the
background knowledge of medicine that helps to re-
assure the patients with non-cardiac chest pain that they
understand their ‘medical’ problems; conversely, cardiac
support nurses are excellent in this latter understanding
but not so skilled in the former [6]. In the proposed
study we have trained general nurses to a high standard
(using formal fidelity checks with an approved scale) for
this adapted form of cognitive behaviour therapy for
non-cardiac chest pain and feel that both of the above
requirements are now being met.
A recent pilot study in this population [7] has also
demonstrated greatly reduced usage of accident and
emergency service contact and in-patient bed usage after
CBT, and so we judge that there is a strong possibility
that the treatment will more than pay for itself in cost
savings. We think we have such a treatment, and so are
conducting a randomised controlled trial comparing
adapted cognitive behaviour therapy for such patients,
delivered by a trained team within the clinic, with stand-
ard support and reassurance in the clinic (standard treat-
ment) and to compare outcomes in terms of symptoms,
social functioning, hospital and emergency department
attendances and admissions, over a period of 12 months.
Full details will be obtained of all health service costs as
it is predicted that, if the active treatment is successful,
patients will attend hospital less often and have fewer in-
vestigations, and this will more than offset the cost of
the psychological treatment.
Tyrer et al. BMC Psychology  (2015) 3:41 Page 2 of 7
Methods/design
The design is a two-arm parallel design randomized con-
trolled trial carried out in three centres that compares a
modified form of cognitive behaviour therapy for chest
pain (CBT-CP) that also includes elements of a similar
successful treatment for health anxiety (CBT-HA [8] that
has been found to have lasting benefit in reducing symp-
toms, as well as showing superiority for nurse-delivered
treatment [9].
The study has two major research questions:
a) does an adapted form of cognitive behaviour therapy
for non-cardiac chest pain given between 2 to 6
sessions, lead to reduced anxiety over health over
6 months and one year?
b) does this adapted form of cognitive behaviour
therapy reduce health service costs over a period of
one year?
These hypotheses, together with related secondary
ones, are being tested in a two-arm parallel randomised
controlled trial of 2–6 sessions of cognitive behaviour
therapy for chest pain (CBT-CP) or standard treatment
(ST) in patients presenting with non-cardiac chest pain
to cardiology settings who have presented at least once
before in the previous year and do not have cardiac
pathology of sufficient severity to explain the symptoms.
Our previous work has suggested that most of these
patients can be treated successfully in a relatively short
number of sessions with an adapted form of cognitive
behaviour therapy (CBT), although a minority of handi-
capped patients may need more. The randomisation
was carried out by an independent Clinical Trials Unit
(Health Services Unit, CHaRT, University of Aberdeen
with equal allocation to CBT and ST, with initial help
given from Open-CDMS, a similar independent unit.
Standard treatment (ST) will consist of normal manage-
ment at the clinics concerned, consisting of investiga-
tive procedures to exclude pathology and feedback to
patients about the findings.
Assessments of outcome include reduction in health
anxiety recorded with the Health Anxiety Inventory
[10] (primary outcome at 6 months), and Lucock Health
Anxiety Questionnaire [11] adapted with agreement of
the author for chest pain, self-completed analog ratings
of both the frequency and severity of chest pain and dis-
comfort developed with the aid of a patient (Inskip
Scale), self-ratings of generalised anxiety and depression
(using the HADS scale) [12], social functioning using
the Social Functioning Questionnaire (SFQ) [13], The
Schedule for Evaluating Persistent Symptoms (SEPS)
[14, 15], that has been found in preliminary studies to
be an accurate measure of medically unexplained symp-
toms, and quality of life using the EQ-5D scale [16] six
months and one year (all secondary outcomes). In
addition, all health service related costs will be recorded
in the 6 months before randomisation and at 6 month
intervals subsequently until one year and the costs for
patients in the two arms of the trial compared.
Target number of participants
From previous work with the Health Anxiety Inventory
we calculated that a difference between the scores of 4
points is a clinically significant difference (but this is
currently being reassessed as 2 may be a more appropri-
ate value). Using data from a similar randomised con-
trolled trial [17] we demonstrated a significant benefit
between CBT and control with a sample of 49 patients.
In this study with a standard deviation for the change of
HAI at 1 year as 6.0 a sample size of 96 patients would
be have 90 % power to demonstrate significance at the
two-sided 5 % significance level. However, it is expected
that a current very similar project in New Zealand under
the supervision of RM, with HT as an applicant, will
provide very similar data from at least a subset of their
sample that will allow some form of combination of
data, such as individual meta-analysis, that will add to
the power of the study.
Ethics and consent
All patients recruited to the study are initially referred
by clinical staff involved in their care and are then seen
by a research assistant who gives each person a partici-
pant information sheet and explains the study. If, after
getting appropriate answers to questions, patients agree
to take part in the randomised study, they sign a declar-
ation of informed consent. The study has been approved
by the NRES (Ethical) Committee East Midlands, North-
ampton, UK (11/EM/0376).
Procedure
The patients seen are those satisfying the criteria below
who presented with chest pain to either cardiology
clinics and/or accident and emergency departments at
three hospitals, King's Mill Hospital, Sutton-in-Ashfield,
Nottinghamshire, the Hillingdon Hospital, Middlesex
and the Royal Berkshire Hospital, Reading. Two other
centres were included but the lack of a local principal
investigator prevented recruitment. The procedures for
the chest pain pathway are not the same at these three
hospitals but are likely to be representative of the UK as
in most hospitals there is no standard pathway for the
assessment of non-cardiac chest pain.
Inclusions and exclusion criteria
The criteria for inclusion are (a) significant chest pain
on at least two separate occasions in the past year in
which no significant pathology explaining the symptoms
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was found, (b) signed consent to take part in the
study, (c) age between 18 and 75. The exclusion cri-
teria are (a) under active psychiatric care, (b) having
received a prescription of a new psychoactive drug
within the previous two months, (c) receiving, or on
waiting list for, a formal psychological treatment.
Those who are currently stable and on regular psy-
choactive medication (for more than 2 months) are
eligible for the study.
Randomisation
Patients who are identified as eligible for the trial by cardi-
ology and accident and emergency staff, and willing to
take part, were first assessed by an independent research
assistant. After baseline assessment all ratings and demo-
graphic details are recorded on a secure on-line data base,
initially Open-CDMS in London and from 2014, CHaRT
in the Health Services Research Unit, University of
Aberdeen. Patients are then allocated to either CBT-CP or
standard care in permuted stacked blocks (do we specify
numbers) stratified by study centre. The allocated treat-
ment is then passed to the trial coordinator (SC) who, if
the patient is allocated to CBT-CP, informs the next avail-
able therapist at the centre concerned and then the
patient, GP and consultant. Patients allocated to standard
care are informed by letter or phone call and the GP and
hospital team also notified. Follow up assessments are
carried out by research assistants ignorant of original allo-
cation after 6 and 12 months. All data are kept by CHaRT
until the termination of the trial.
Experimental interventions
Adapted CBT-CP (CBT for Chest Pain)
This will be given by staff trained and supervised by
HT. This is similar in several ways to cognitive behav-
iour therapy for health anxiety (CBT-HA) [8] and its
essential features are
(i) A formulation made for a recent episode of chest
pain with its central fear associations and possible
consequences (by end of first session),
(ii) assessment of the behaviours that are maintaining
the chest pain,
(iii) introducing the Beck equation of likelihood times
awfulness divided by coping skills times rescue factors
(a much larger issue for chest pain than for most other
symptoms),
(iv) building up a model of the cognitive theory of
emotion with illustrations where necessary of the
nature of symptoms,
(v) introducing the model of fear of having heart
disease/more serious heart disease (in those with pre-
existing cardiac pathology) versus actually having heart
disease/more serious heart disease,
(vi) introducing the pie chart and pyramid systems for
interpreting other worrying but innocuous symptoms,
(vii) trying to influence the over-developed sense of
responsibility that the patient feels is necessary to
monitor the progress of, and likely interventions for,
the chest pain,
(viii) using the patient's strengths in finding alternative
strategies of dealing with chest pain,
(ix) developing a strategy for managing risk (highly
important in this population),
(x) diary homework to illustrate the relationship
between symptoms and events likely to provoke
anxiety.
In preliminary work we have found in some cases only
one or two sessions of 50–60 min are needed to
complete treatment but in others many more sessions
are needed, particularly if the chest pain has become
chronic.
Standard care
This constitutes the care that is currently given to patients
in primary and secondary care at present; this involves
appropriate testing, explanation of findings, reassurance of
the implications of these and the opportunity for the
patient to ask questions about the symptoms and the test
results.
Economic analysis
The economic evaluation will take a health care perspec-
tive and, using the service use data collected over follow-
up, will calculate the total cost of the services used by each
study participant. These costs will be taken together with
the cost of the CBT to generate average costs for each
randomised group. These costs will be compared using
standard t-tests, which are recommended for economic
analysis because they allow for analysis of mean costs
without transformation. The robustness of this approach
will be checked through the calculation of bootstrapped
confidence intervals [18, 19]. A cost-utility analysis will
also be carried out where the costs in the CBT-CP and ST
groups will be compared alongside the difference in
QALYs, derived from the EQ-5D.
Primary and secondary outcomes
The primary outcome is the reduction in scores on the
Health Anxiety Inventory between baseline and 6 months,
Secondary outcomes are (i) the reduction in visual analog
scores of frequency and intensity of chest pain, (ii) reduc-
tion in Lucock scores, (iii) reduction in the total SEPS
score, (between baseline and 6 months and one year, (ii)
the number of attendances at Accident & Emergency
Departments after 6 months and one year, (iii) total health
service costs in primary and secondary care at 6 and
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12 months, (iv) reduction in generalised anxiety symptoms
(on the HADS-Anxiety Scale after 6 months and 1 year,
(v) reduction in depressive symptoms on the HADS-
Depression Scale at the same time points, and (vi) change
in mean Lucock scores from baseline after one year.
Analyses
All analyses will be by intention to treat, analysed as rando-
mised. The primary analysis will compare mean change
scores of the Health Anxiety Inventory scale from the
baseline to 6 months between the treatment and control
groups. We shall conduct sensitivity analyses to examine
data missing mechanism to decide whether imputation ap-
proaches are necessary. Random effects regression model
will be used to estimate and test differences of mean
change scores between the two comparison groups at 6
and 12 months simultaneously with adjustment for base-
line score and key variables used for minimisation proced-
ure. We shall also examine distribution of the outcome
score. If a skewed distribution such as a Poisson one was
shown, data transformation such as logarithmic transform-
ation of raw data will be carried out before any statistical
analysis.
Analyses of secondary outcomes will follow the same
analytic procedure and statistical approaches. Economic
analysis will follow a similar methodology except that
wherever possible data will be analysed without trans-
formation and using bootstrapping techniques for skewed
data [18, 19].
Fidelity of treatment
Each therapist will be trained by HT and assessed in vivo
at interviews with patients using an adaptation of the
Cognitive Therapy Rating Scale (CTRS), a necessary
change for a population that largely regards its anxiety
as an appropriate mood to monitor health [20]. Supervi-
sion in vivo will continue until at least a 75 % of
maximum score is achieved.
Fig. 1 COPIC Trial Profile
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Status of the trial
Recruitment to the study began in July 2012 and the last
patient was recruited in January 2015. No data have cur-
rently been examined. The CONSORT diagram illustrates
the high numbers of people who present with potential
non-cardiac chest pain (Fig. 1). 68 patients were recruited,
a lower level than planned, but the revision in the clinic-
ally important difference (see above) makes the study only
slightly underpowered.
Discussion
The trial has been a difficult one to undertake because of
the several ways in which non-cardiac chest pain is
assessed in general. It has also highlighted a lack of close
liaison between accident and emergency and cardiology
departments, and surprise among many cardiologists that
so many patients with non-cardiac chest pain are seen and
discharged by accident and emergency staff without ever
seeing a specialist in cardiology. There was also some evi-
dence that dogmatic reluctance to follow any other route
different from the standard investigation pathway some-
times hinders acceptance of a likely psychological explan-
ation for symptoms. This is also reflected in the relatively
high proportion of patients who refused randomisation
(37 %) after passing through all other part of the assess-
ment process. This reluctance to take part in psychological
interventions has been noted by others in this field [6] and
will probably only be overcome by increasing mental
health literacy in both patients and hospital staff.
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